Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
|Articles|September 14, 2021
Pharmacy Clinical Pearl of the Day: Head Lice
Author(s)Saro Arakelians, PharmD
Treatment options for head live include Permethrin (Nix) and Pyrethrin (Rid) as OTC options and prescription medicines such as Ivermectin (Sklice), Spinosad (Natroba), and Malathion.
Advertisement
Clinical Pearl of the Day: Head Lice
- Head lice are tiny insects that feed on blood from the human scalp.
Explanation:
- An infestation of head lice most often affects children.
- It usually results from the direct transfer of lice from the hair of one person to another.
- Symptoms include itching, lice on scalp, lice eggs on hair shafts, and sores on the scalp, neck, and shoulders.
- Treatment options include Permethrin (Nix) and Pyrethrin (Rid) as OTC options and prescription medicines such as Ivermectin (Sklice), Spinosad (Natroba) and Malathion.
- Other alternative options would be wet-combing, essential oils, smothering agents, and dehydration applied to skin.
Reference:
Advertisement
Related to this article
Insulin efsitora alfa-gobe (Onswik; Eli Lilly) is designed to deliver steady basal insulin levels over a full 7-day duration.
Vallerie McLaughlin, MD, explains why the ERS update strongly recommends sotatercept for patients with pulmonary arterial hypertension (PAH) who don't reach low-risk status on initial therapy.
Imaging data from the CONTENTed study suggest the type 2 inflammation that drives severe asthma may affect more than the airways.
Renal benefit appeared only in patients with albuminuria in a 75,455-person BMJ analysis, whereas sulfonylureas signaled faster decline without it.
Authors of a pharmacist-directed transitions-of-care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
HYPERION trial data now support sotatercept within a patient's first year of pulmonary arterial hypertension (PAH) diagnosis, cutting clinical worsening risk by 76% compared with placebo.
A stewardship program combining EHR alerts and pharmacist-led education offers a replicable model for reducing bleeding risk.
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
3
FDA Approves Belzutifan Plus Lenvatinib for Advanced Renal Cell Carcinoma After Immunotherapy
4
Alcohol and GLP-1 Therapy: Key Counseling Points for Pharmacists
5